XLK vs SMH: returns, risk and drawdowns compared
Technology Select Sector SPDR Fund against VanEck Semiconductor ETF, over the same 19 years (December 2006 to October 2026) with dividends reinvested.
Data updated October 2026
XLK
Technology Select Sector SPDR Fund
10,000 became
87,249
- A year on average
- +11.5%
- Annual volatility
- 22.0%
- Deepest fall
- −50.5%
- Worst month
- −45.0%
SMH
VanEck Semiconductor ETF
10,000 became
468,690
- A year on average
- +21.3%
- Annual volatility
- 26.0%
- Deepest fall
- −52.0%
- Worst month
- −19.5%
SMH came out ahead by 9.8 percentage points a year from December 2006 to October 2026. SMH swung more (26.0% against 22.0% a year). The correlation of monthly returns was 0.72: they usually moved together.
Growth of 10,000: XLK vs SMH
Who was ahead, and when
The gap between the two over the previous three years, at each month-end. Above zero XLK had returned more, below zero SMH. XLK was ahead in 13% of the 204 three-year periods.
Annualised 3-year return of XLK minus that of SMH, in percentage points a year.
Falls from the previous high
Month-end values. Deepest fall: XLK −50.5%, SMH −52.0%.
All the figures
| XLK | SMH | |
|---|---|---|
| Annual return (CAGR) | +11.5% | +21.3% |
| Total return | +772% | +4587% |
| Annual volatility | 22.0% | 26.0% |
| Deepest fall (month-end) | −50.5% | −52.0% |
| Worst month | −45.0% | −19.5% |
| Best month | +20.0% | +32.2% |
| Positive months | 62% | 64% |
| Best year | 2023: +55.4% | 2023: +73.4% |
| Worst year | 2008: −41.9% | 2008: −44.8% |
| 1-year return | +18.9% | +57.8% |
| 5 years, a year | +1.2% | +33.2% |
| 10 years, a year | +14.7% | +33.0% |
| Trading currency | USD | USD |
First nine rows: the same 239 months for both funds. Trailing returns: to each fund’s last close.
Year by year
Full calendar years both funds were trading. The higher of the two each year is in bold.
Holding both: half XLK, half SMH
| XLK alone | SMH alone | 50/50 | |
|---|---|---|---|
| A year on average | +11.5% | +21.3% | +16.9% |
| Annual volatility | 22.0% | 26.0% | 22.2% |
| Deepest fall (month-end) | −50.5% | −52.0% | −50.2% |
| Worst month | −45.0% | −19.5% | −16.0% |
Because the two did not always move together, the mix swung less than the average of the two (22.2% against 24.0%). Rebalanced to 50/50 every month, before costs.
Questions
Which has returned more, XLK or SMH?
From December 2006 to October 2026, XLK returned +11.5% a year and SMH +21.3% a year, with dividends reinvested. Over rolling 3-year periods XLK did better in 13% of cases. Past returns do not predict future returns.
Which is riskier, XLK or SMH?
Over the same months annual volatility was 22.0% for XLK and 26.0% for SMH; the deepest fall from a month-end high was 50.5% and 52.0%, and the worst single month −45.0% and −19.5%.
How correlated are XLK and SMH?
The correlation of their monthly returns was 0.72: they usually moved together. Combining them has historically given some diversification.
What about holding both XLK and SMH?
Half in each, rebalanced every month, returned +16.9% a year over the same period, with 22.2% annual volatility and a deepest month-end fall of 50.2%.
More comparisons
- XLK — Technology Select Sector SPDR FundReturns, drawdowns and risk
- SMH — VanEck Semiconductor ETFReturns, drawdowns and risk
- XLK vs SOXX
- QQQ vs XLK
- SMH vs SOXX
- QQQ vs SMH
- Portfolio stress test with custom shocksYour own scenarios, holding by holding
- Portfolio Visualizer alternativesWhich tool fits which job
How the figures are calculated
Total return in the fund’s trading currency, from end-of-day prices with dividends reinvested on the ex-date. The fund’s own ongoing charges are already reflected in its price; trading costs, taxes and currency conversion are not included. Past returns do not predict future returns.
The comparison uses only the months in which both funds have prices, so the figures cover the same period even when one fund is older.
Source: MarketStack end-of-day prices, total return with dividends reinvested. Figures are historical and descriptive; they are not forecasts and not investment advice. MEDGE Capital does not recommend buying or selling any instrument. Risk disclaimer.